Amalgamated Bank’s NxStage Medical Inc. NXTM Stock Holding History

Amalgamated Bank’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,529	Closed	-$273K	–	1716
2018 Q4	$273K	Buy	+9,529	New	+$271K	0.01%	1230
2018 Q3	–	Sell	-10,073	Closed	-$281K	–	1719
2018 Q2	$281K	Buy	10,073 +1,388	+16%	+$37.2K	0.01%	1364
2018 Q1	$216K	Sell	8,685 -147	-2%	-$3.58K	0.01%	1412
2017 Q4	$214K	Buy	8,832 +579	+7%	+$15.3K	0.01%	1464
2017 Q3	$228K	Sell	8,253 -104	-1%	-$2.77K	0.01%	1370
2017 Q2	$210K	Buy	8,357 +553	+7%	+$13.7K	0.01%	1415
2017 Q1	$209K	Sell	7,804 -5	-0.1%	-$138	0.01%	1356
2016 Q4	$205K	Buy	+7,809	New	+$193K	0.01%	1378

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Amalgamated Bank's NXTM Position: Q1 2019 in Review

Amalgamated Bank sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 9,529 shares — an estimated $273K sold.

Amalgamated Bank first reported a position in NXTM in Q4 2016 and held it in 8 quarters. The position peaked at $281K in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Amalgamated Bank reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Amalgamated Bank sold 9,529 NxStage Medical Inc. shares in Q1 2019, an estimated $273K.
Amalgamated Bank first reported a position in NxStage Medical Inc. in Q4 2016 and held it in 8 quarters.
Amalgamated Bank's NxStage Medical Inc. position peaked at $281K in Q2 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Amalgamated Bank's 13F filing for Q1 2019, filed 15 May 2019.